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Oral submucous fibrosis (OSF) is a debilitating irreversible fibrotic condition of the oral cavity. 
It is characterized by inflammation and ultimately results in trismus. Patients face difficulty in 
speaking, swallowing and chewing due to restricted mouth opening (trismus). This disease is 
also categorized as an oral premalignant disorder (OPMD). Recent reports cite a conversion rate 
of 10% from OSF to oral squamous cell carcinoma (OSCC). Epidemiological studies and case 
reports over the years have correlated the habit of chewing areca nut (Areca catechu) to the 
manifestation of OSF. It is a major cause of concern in the South and South East Asian parts of 
the world where areca nut is cultivated and routinely consumed. There are an estimated 700 
million areca nut chewers around the globe with 0.5% of the population in the Indian 
subcontinent being affected by OSF due to this habit. 
 
Previous studies have reported differential gene expression profile and up regulation of the pro-
fibrotic transforming growth factor-β (TGF-β) pathway in OSF. However, detailed molecular 
mechanisms for the pathogenesis of this disease are still unclear despite our knowledge about the 
etiological agent (areca nut) responsible for its progression. Therefore, to gain insights into the 
etiopathogeneses of OSF, following objectives were undertaken: 
 
 To study the gene expression changes induced by areca nut and pro-fibrotic cytokine 
TGF-β in primary fibroblast cells, and their implications in OSF. 
 To elucidate the mechanism of TGF-β signal activation in epithelial cells by areca nut. 
 
Fibroblast cells are the effectors in all fibrotic disorders. Therefore, it is essential to study the 
response of this cell type in fibrosis. With prior knowledge of the activation of TGF-β pathway 
in OSF and the etiological agent of this disease being areca nut; we wanted to study the 
differential gene response of fibroblasts to these two agents.  
For this purpose, human primary gingival fibroblasts (hGF) were used as a model system to 
study the global gene expression profile regulated by areca nut and/or TGF-β. hGF cells were 
treated with sub-cytotoxic dose of areca nut (5 µg/ml) with and without TGF-β (5 ng/ml) for 72 
hours and microarray was performed. The results revealed 4666 genes being differentially 
regulated by areca nut in hGF cells while TGF-β regulated 1214 genes. Both of them together 
                                                                                                                                              





differentially regulated 5752 genes. 413 genes which were commonly regulated by areca nut and 
TGF-β were observed to have enhanced regulation with a combined treatment of areca nut, 
together with TGF-β. This result pointed towards the potential role of both areca nut and TGF-β 
in modulating fibroblast response. 
To further assess the role of areca nut in OSF manifestation, we first compared the transcriptome 
profile induced by it in epithelial cells with fibroblast cells. Areca nut was found to induce 
differential response in these two cell types which corroborates with the disease pathology 
wherein; epithelial atrophy is observed and conversely fibroblasts are proliferative. To extend 
these observations we compared the areca nut induced profile in epithelial cells with OSF 
differential profile and found that a majority of the genes regulated by areca nut which were 
common with OSF are regulated by TGF-β. Similarly, areca nut and TGF-β regulated profile in 
fibroblast cells overlapped significantly with OSF profile. Additionally, areca nut and TGF-β 
treatment positively enriched matrix associated and metabolic pathways among others which are 
reported to be differentially regulated in OSF. These observations also highlighted the 
importance of combined actions of areca nut and TGF-β in OSF manifestation. 
To test the physiological importance of combined actions of areca nut and TGF-β in the context 
of OSF; activation of fibroblasts by these treatments was assessed. Treatment of fibroblasts with 
areca nut and TGF-β enhanced the expression of myofibroblast markers αSMA and γSMA with a 
concomitant increase in the contractile property when compared to areca nut or TGF-β treatment 
alone. 
Further, we observed that areca nut did not regulate any of the TGF-β ligands or receptors in 
fibroblasts, whereas it induced TGF-β2 in epithelial cells. Therefore, this invoked a possible 
epithelial-mesenchymal interaction that may exist in OSF pathogenesis. To test this possibility 
in-vitro, epithelial cells were treated with areca nut and the secretome of these cells was put on 
hGF cells to study the regulation of fibrosis associated genes. This treatment enhanced the 
regulation of fibroblast activation markers (αSMA and γSMA) as compared to direct areca nut 
treatment. This increase in regulation was abrogated when induction of TGF-β2 was 
compromised in epithelial cells. Similar results were obtained for the regulation of other genes 
(TGM-2, THBS-1, EDN1, LOXL3, PLOD2, TMEPAI, TGFBI, CTGF, BMP1, LMIK1). 
Therefore, we concluded that TGF-β which is secreted in response to areca nut by epithelial cells 
                                                                                                                                              





influences fibroblasts in combination with areca nut to enhance fibrosis response. Furthermore, 
the secretome of untreated epithelial cells was found to down regulate the basal expression of 
fibrosis related genes in fibroblasts, invoking a role for epithelial secretome in regulating the 
fibrosis progression.  
Our data highlighted the importance of TGF-β’s influence on fibroblast response in OSF, but the 
mechanism for the regulation of this cytokine was not known. Areca nut did not induce TGF-β 
ligands in fibroblast as discussed above, but previous data from our group had reported areca nut 
mediated up regulation of TGF-β2 in epithelial cells. Therefore, we further elucidated the 
mechanistic details for this induction using immortalized keratinocytes (HaCaT and HPL1D) and 
correlated these in OSF tissues.  
The kinetics of the induction of TGF-β signaling by areca nut (5 µg/ml) in epithelial cells was 
established. Areca nut induced TGF-β2 transcript, protein and activated the canonical signaling 
(pSMAD2/3) at 2 hours post treatment, which persisted till 24 hours. The regulation of TGF-β2 
mRNA at 2 hours was dependent on active transcription but was independent of protein 
translation whereas the activation of signaling (pSMAD2) required both transcription and 
translation at this time point. This warranted probing for the role of TβR-I in the activation of 
TGF-β signal by areca nut. A small molecule inhibitor was used to abrogate the kinase activity of 
TβR-I. Areca nut induced TGF-β2 mRNA at 2 hours even in the presence of TβR-I inhibitor 
whereas the induction was compromised at 24 hours although the activation of SMAD2 at both 2 
and 24 hours was compromised in the presence of TβR-I. This result signified that induction of 
TGF-β signaling was dependent on the TβR-I activity at early and late time points, but the 
transcription of the ligand was independent of the receptor activity at early time point.  
These results indicated the activation of some other pathway by areca nut which could regulate 
the transcription of TGF-β2 and thereby activate TGF-β signaling in epithelial cells. To explore 
this possibility, a panel of pathway inhibitors was used and only JNK inhibitor compromised 
areca nut induced TGF-β2 mRNA and pSMAD2. The results were corroborated by transient 
knockdown of JNK1 and JNK2. Further, JNK was phosphorylated at 30 minutes to 2 hours by 
areca nut treatment on epithelial cells. This activation was found to be independent of TβR-I 
activity. In good correlation, activated JNK1/2 was also detected in OSF tissues and was not 
detectable in normal tissues.  
                                                                                                                                              





Since JNK activation was found to be a pre-requisite for areca nut induced TGF-β signal 
activation; we further explored the mechanism of JNK activation by areca nut itself. Areca nut 
mediated activation of JNK was found to be dependent on muscarinic acid receptor, 
Ca2+/CAMKII and ROS. Inhibition of these significantly compromised areca nut induced pJNK. 
In line with this, inhibition of muscarinic acid receptor activity, CAMKII and ROS also 
abrogated areca nut mediated induction of TGF-β2 mRNA and pSMAD2. 
The regulation of TGF-β signaling by areca nut in epithelial cells was dependent on 
transcription, and JNK activity was essential for this. We further sought to explore transcription 
factors which were regulated by JNK and therefore could possibly induce TGF-β2 promoter 
activity. ATF2 and c-Jun transcription factors were found to be induced at 30 minutes by areca 
nut and this up regulation also persisted till 24 hours. Further, activation of both ATF2 and c-Jun 
was dependent on JNK but independent of TβR-I activity. Moreover, areca nut treatment induced 
translocation of these phoshorylated transcription factors in the nucleus of epithelial cells. 
Additionally, pATF2 and p-c-Jun were enriched on TGF-β2 promoter after 2 hours of treatment 
by areca nut. To investigate the importance of this enrichment and regulation of TGF-β signal 
activation by areca nut, we transiently knocked down these proteins and studied the regulation of 
TGF-β2. Areca nut induced TGF-β2 mRNA and pSMAD2 was abrogated upon ATF2 and c-Jun 
knockdown, implicating JNK mediated activation of ATF2 and c-Jun in areca nut induced TGF-
β signaling. To explore the significance of this mechanism in OSF, immunohistochemical 
staining for pATF2 and p-c-Jun was performed on OSF and normal tissues. Both the 
transcription factors were found in the nuclei of OSF tissues whereas their expression was not 
detected in normal tissues. This expression also correlated with the previously reported 
activation of SMAD2 in OSF tissues by our group. Hence, ATF2 and c-Jun were observed to be  
important in areca nut mediated TGF-β signaling in OSF. 
In conclusion, the work described in this thesis provides mechanistic details into OSF 
etiopathogenesis. Combined actions of areca nut and TGF-β induced a response in fibroblasts 
akin to OSF. Our results advocate a role for epithelial secreted factors in influencing fibroblast 
response in both normal and disease (OSF) conditions. Further, importance of TGF-β in OSF has 
been elucidated in terms of enhancing the fibroblast response to areca nut. We have also 
elucidated the mechanism for areca nut mediated activation of TGF-β signaling and have 
                                                                                                                                              





identified the contribution of JNK/ATF2/Jun axis in this process. This work can impact the 
management of oral submucous fibrosis by providing newer targets for treatment. 
